2023
Management of Anal Incontinence With Implantable Sacral Neuromodulation
Esposito A, Mongiu A. Management of Anal Incontinence With Implantable Sacral Neuromodulation. Diseases Of The Colon & Rectum 2023, 66: 758-762. PMID: 36989061, DOI: 10.1097/dcr.0000000000002890.Peer-Reviewed Original Research
2010
Reconstruction of late‐onset transplant ureteral stricture disease
Helfand BT, Newman JP, Mongiu AK, Modi P, Meeks JJ, Gonzalez CM. Reconstruction of late‐onset transplant ureteral stricture disease. BJU International 2010, 107: 982-987. PMID: 20825404, DOI: 10.1111/j.1464-410x.2010.09559.x.Peer-Reviewed Original ResearchConceptsTransplant ureteral stricturesUreteral strictureGraft failureImmunosuppressive drug regimenKidney-pancreas transplantationStable allograft functionBaseline clinical characteristicsSerum creatinine levelsUrinary tract infectionLarge patient cohortUreteral stricture diseaseTime of reconstructionAllograft functionPostoperative complicationsRenal transplantationClinical characteristicsCreatinine levelsDrug regimenTract infectionsBalloon dilationMedian ageRepeat dilationStricture recurrenceSurgical managementOpen reconstruction
2009
Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease
Helfand BT, Mongiu AK, Kan D, Kim D, Loeb S, Roehl KA, Meeks JJ, Smith ND, Catalona WJ. Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease. BJU International 2009, 104: 304-309. PMID: 19239451, DOI: 10.1111/j.1464-410x.2009.08421.x.Peer-Reviewed Original ResearchConceptsRadical retropubic prostatectomyClinical stage T1c diseaseStage T1c diseaseT1b diseaseT1c diseaseGleason scoreB diseasePathological featuresProstate cancerLower preoperative prostate-specific antigen levelsFavorable long-term functional outcomesPreoperative prostate-specific antigen levelLower cancer-specific survivalProstate-specific antigen levelLong-term functional outcomeClinical stage T1aStage T1b diseaseT1a/bT1b prostate cancerAdverse pathological featuresCancer-specific survivalOrgan-confined diseaseYear of surgeryOverall survival rateAggressive pathological features